Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,614 | 139 | 99.5% |
| Education | $14.00 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $418.59 | 18 | $0 (2023) |
| Lilly USA, LLC | $361.48 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $332.35 | 17 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $330.42 | 20 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $206.69 | 4 | $0 (2018) |
| PFIZER INC. | $184.78 | 11 | $0 (2024) |
| Amarin Pharma Inc. | $87.93 | 6 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $76.36 | 1 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $66.90 | 5 | $0 (2019) |
| ABBVIE INC. | $65.48 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $392.35 | 20 | Lilly USA, LLC ($141.17) |
| 2023 | $232.69 | 15 | Lilly USA, LLC ($122.36) |
| 2022 | $282.24 | 18 | SANOFI-AVENTIS U.S. LLC ($91.23) |
| 2021 | $568.85 | 26 | Boehringer Ingelheim Pharmaceuticals, Inc. ($112.67) |
| 2020 | $148.07 | 10 | Boehringer Ingelheim Pharmaceuticals, Inc. ($51.73) |
| 2019 | $270.84 | 12 | Novo Nordisk Inc ($161.03) |
| 2018 | $527.68 | 25 | Ironwood Pharmaceuticals, Inc ($189.75) |
| 2017 | $205.75 | 14 | Amgen Inc. ($32.94) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: PAIN | ||||||
| 12/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Diabetes | ||||||
| 11/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Cardio-renal | ||||||
| 09/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $49.26 | General |
| Category: DIABETES | ||||||
| 06/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: DIABETES | ||||||
| 06/14/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: PAIN | ||||||
| 06/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Endocrinology | ||||||
| 05/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/26/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Diabetes | ||||||
| 04/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Diabetes | ||||||
| 04/12/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Diabetes | ||||||
| 04/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: PAIN | ||||||
| 02/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: VACCINES | ||||||
| 01/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/22/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Neuroscience | ||||||
| 07/28/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Neuroscience | ||||||
| 07/15/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Diabetes | ||||||
| 06/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: RESPIRATORY | ||||||
| 06/23/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 806 | 1,078 | $166,815 | $69,331 |
| 2022 | 18 | 833 | 1,090 | $131,397 | $62,961 |
| 2021 | 15 | 1,106 | 1,562 | $198,773 | $99,536 |
| 2020 | 17 | 1,155 | 1,603 | $175,576 | $86,296 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 185 | $47,720 | $17,220 | 36.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 103 | 103 | $21,160 | $13,360 | 63.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 213 | $37,772 | $12,442 | 32.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 100 | 100 | $17,995 | $6,642 | 36.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 30 | $10,475 | $4,036 | 38.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 58 | 58 | $4,445 | $3,727 | 83.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 16 | $7,905 | $3,428 | 43.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 53 | 91 | $5,890 | $2,371 | 40.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $4,422 | $1,994 | 45.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 55 | $2,750 | $1,719 | 62.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 54 | 54 | $1,620 | $993.06 | 61.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 35 | 58 | $1,745 | $552.16 | 31.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $700.00 | $419.00 | 59.9% |
| G0102 | Prostate cancer screening; digital rectal examination | Office | 2023 | 17 | 17 | $823.00 | $220.95 | 26.8% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 19 | 19 | $195.00 | $116.09 | 59.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 24 | 25 | $1,000 | $54.18 | 5.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 17 | $198.00 | $37.40 | 18.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 11 | $0.11 | $0.11 | 100.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 160 | $35,200 | $14,310 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 215 | $32,250 | $13,056 | 40.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 83 | 83 | $18,675 | $11,015 | 59.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 108 | 111 | $12,210 | $7,736 | 63.4% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 56 | 60 | $5,130 | $4,089 | 79.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 13 | $4,745 | $2,944 | 62.1% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 58 | 102 | $8,160 | $2,766 | 33.9% |
About Dr. Mark Sawka, MD
Dr. Mark Sawka, MD is a Family Medicine healthcare provider based in Woodhaven, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609873496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Sawka, MD has received a total of $2,628 in payments from pharmaceutical and medical device companies, with $392.35 received in 2024. These payments were reported across 140 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,614).
As a Medicare-enrolled provider, Sawka has provided services to 3,900 Medicare beneficiaries, totaling 5,333 services with total Medicare billing of $318,123. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Woodhaven, MI
- Active Since 07/07/2005
- Last Updated 12/28/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609873496
Products in Payments
- JARDIANCE (Drug) $189.48
- NURTEC ODT (Drug) $177.64
- DUZALLO (Drug) $171.56
- STIOLTO RESPIMAT (Drug) $144.70
- Tresiba (Drug) $124.74
- TOUJEO (Drug) $113.53
- EMGALITY (Drug) $112.71
- Ozempic (Drug) $106.81
- SOLIQUA 100/33 (Biological) $97.86
- Vascepa (Drug) $87.93
- XIFAXAN (Drug) $86.95
- RYBELSUS (Drug) $77.72
- Victoza (Drug) $77.61
- SPIRIVA RESPIMAT (Drug) $70.80
- TRULICITY (Drug) $67.76
- MOUNJARO (Drug) $65.18
- TOUJEO (Biological) $63.49
- UBRELVY (Drug) $51.79
- TRELEGY ELLIPTA (Drug) $43.42
- CHANTIX (Drug) $41.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Woodhaven
Gordon Davis, D.o, D.O
Family Medicine — Payments: $860.22
Dr. Khurram Surani, Md, MD
Family Medicine — Payments: $587.81
Syed Rahman, Md, MD
Family Medicine — Payments: $570.11
Dr. Anna Gladstone, D.o, D.O
Family Medicine — Payments: $298.14
Dr. Giovanni Marciano, Do, DO
Family Medicine — Payments: $277.12
Dr. Glenn Muraca, Do, DO
Family Medicine — Payments: $94.85